Potential skin morbidity reduction with intensity-modulated proton therapy for breast cancer with nodal involvement

References

• Whelan TJ, Olivotto IA, Parulekar WR, et al. Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015;373:307–316.
   PubMed Web of Science ®Google Scholar
• Poortmans PM, Collette S, Kirkove C, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373:317–327.
   PubMed Web of Science ®Google Scholar
• Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987–998.
   PubMed Web of Science ®Google Scholar
• van den Bogaard VA, Ta BD, van der Schaaf A, et al. Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures. JCO. 2017;35:1171–1178.
   PubMed Web of Science ®Google Scholar
• Ares C, Khan S, Macartain AM, et al. Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements? Int J Radiat Oncol Biol Phys. 2010;76:685–697.
   PubMed Web of Science ®Google Scholar
• Ranger A, Dunlop A, Hutchinson K, et al. A dosimetric comparison of breast radiotherapy techniques to treat locoregional lymph nodes including the internal mammary chain. Clin Oncol. (R Coll Radiol) 2018;30:346–353.
   PubMed Web of Science ®Google Scholar
• Tyran M, Mailleux H, Tallet A, et al. Volumetric-modulated arc therapy for left-sided breast cancer and all regional nodes improves target volumes coverage and reduces treatment time and doses to the heart and left coronary artery, compared with a field-in-field technique. J Radiat Res. 2015;56:927–937.
   PubMed Web of Science ®Google Scholar
• Lancellotta V, Iacco M, Perrucci E, et al. Comparing four radiotherapy techniques for treating the chest wall plus levels III-IV draining nodes after breast reconstruction. Br J Radiol. 2018;91:20160874.
   PubMed Web of Science ®Google Scholar
• Braunstein LZ, Cahlon O. Potential morbidity reduction with proton radiation therapy for breast cancer. Semin Radiat Oncol. 2018;28:138–149.
   PubMed Web of Science ®Google Scholar
• Kammerer E, Guevelou JL, Chaikh A, et al. Proton therapy for locally advanced breast cancer: a systematic review of the literature. Cancer Treat Rev. 2018;63:19–27.
   PubMed Web of Science ®Google Scholar
• Bradley JA, Dagan R, Ho MW, et al. Initial report of a prospective dosimetric and clinical feasibility trial demonstrates the potential of protons to increase the therapeutic ratio in breast cancer compared with photons. Int J Radiat Oncol Biol Phys. 2016;95:411–421.
   PubMed Web of Science ®Google Scholar
• Liang X, Bradley JA, Zheng D, et al. Prognostic factors of radiation dermatitis following passive-scattering proton therapy for breast cancer. Radiat Oncol. 2018;13:72.
   PubMed Web of Science ®Google Scholar
• Verma V, Iftekaruddin Z, Badar N, et al. Proton beam radiotherapy as part of comprehensive regional nodal irradiation for locally advanced breast cancer. Radiother Oncol. 2017;123:294–298.
   PubMed Web of Science ®Google Scholar
• Tommasino F, Durante M, D'Avino V, et al. Model-based approach for quantitative estimates of skin, heart, and lung toxicity risk for left-side photon and proton irradiation after breast-conserving surgery. Acta Oncol. 2017;56:730–736.
   PubMed Web of Science ®Google Scholar
• Borm KJ, Loos M, Oechsner M, et al. Acute radiodermatitis in modern adjuvant 3D conformal radiotherapy for breast cancer – the impact of dose distribution and patient related factors. Radiat Oncol. 2018;13:218.
   PubMed Web of Science ®Google Scholar
• Pastore F, Conson M, D’Avino V, et al. Dose-surface analysis for prediction of severe acute radio-induced skin toxicity in breast cancer patients. Acta Oncol. 2016;55:466–473.
   PubMed Web of Science ®Google Scholar
• Langendijk JA, Lambin P, De Ruysscher D, et al. Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. Radiother Oncol. 2013;107:267–273.
   PubMed Web of Science ®Google Scholar
• Widder J, van der Schaaf A, Lambin P, et al. The quest for evidence for proton therapy: model-based approach and precision medicine. Int J Radiat Oncol Biol Phys. 2016;95:30–36.
   PubMed Web of Science ®Google Scholar
• Marvaso G, Vischioni B, Jereczek-Fossa BA, et al. Hadrontherapy from the Italian Radiation Oncologist point of view: face the reality. The Italian Society of Oncological Radiotherapy (AIRO) survey. Radiol Med. 2017;122:140–145.
   PubMed Web of Science ®Google Scholar
• Moreno AC, Shaitelman SF, Buchholz TA. A clinical perspective on regional nodal irradiation for breast cancer. Breast. 2017;34(Suppl 1):S85–S90.
   PubMedGoogle Scholar
• AIRO. La Radioterapia dei Tumori della Mammella: Indicazioni e Criteri Guida [cited 2013]. Available from: http://vecchio.radioterapiaitalia.it/cont__169.phtml
   Google Scholar
• Feng M, Moran JM, Koelling T, et al. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys. 2011;79:10–18.
   PubMed Web of Science ®Google Scholar
• Deasy JO, Blanco AI, Clark VH. CERR: a computational environment for radiotherapy research. Med Phys. 2003;30:979–985.
   PubMed Web of Science ®Google Scholar
• Palma G, Cella L. A new formalism of dose surface histograms for robust modeling of skin toxicity in radiation therapy. Phys Med. 2019;59:75–78.
   Web of Science ®Google Scholar
• Cella L, D’Avino V, Palma G, et al. Modeling the risk of radiation-induced lung fibrosis: irradiated heart tissue is as important as irradiated lung. Radiother Oncol. 2015;117:36–43.
   PubMed Web of Science ®Google Scholar
• Cella L, Liuzzi R, Conson M, et al. Multivariate normal tissue complication probability modeling of heart valve dysfunction in Hodgkin lymphoma survivors. Int J Radiat Oncol Biol Phys. 2013;87:304. 10.
   PubMed Web of Science ®Google Scholar
• Cella L, Liuzzi R, Conson M, et al. Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis. Radiat Oncol. 2012;7:224.
   PubMed Web of Science ®Google Scholar
• Johansson J, Isacsson U, Lindman H, et al. Node-positive left-sided breast cancer patients after breast-conserving surgery: potential outcomes of radiotherapy modalities and techniques. Radiother Oncol. 2002;65:89–98.
   PubMed Web of Science ®Google Scholar
• Fogliata A, Bolsi A, Cozzi L. Critical appraisal of treatment techniques based on conventional photon beams, intensity modulated photon beams and proton beams for therapy of intact breast. Radiother Oncol. 2002;62:137–145.
   PubMed Web of Science ®Google Scholar
• Lomax AJ, Cella L, Weber D, et al. Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes. Int J Radiat Oncol Biol Phys. 2003;55:785–792.
   PubMed Web of Science ®Google Scholar
• Lomax A. Intensity modulation methods for proton radiotherapy. Phys Med Biol. 1999;44:185–205.
   PubMed Web of Science ®Google Scholar
• Cella L, Lomax A, Miralbell R. New techniques in hadrontherapy: intensity modulated proton beams. Phys Med. 2001;17:100–102.
   PubMed Web of Science ®Google Scholar
• Mohan R, Grosshans D. Proton therapy – present and future. Adv Drug Deliv Rev. 2017;109:26–44.
   PubMed Web of Science ®Google Scholar
• Verma V, Simone CB II, Mishra MV. Quality of life and patient-reported outcomes following proton radiation therapy: a systematic review. J Natl Cancer Inst. 2018;110:341–353.
   Google Scholar
• Verma V, Shah C, Mehta MP. Clinical outcomes and toxicity of proton radiotherapy for breast cancer. Clin Breast Cancer. 2016;16:145–154.
   PubMed Web of Science ®Google Scholar
• Dorr W, Hendry JH. Consequential late effects in normal tissues. Radiother Oncol. 2001;61:223–231.
   PubMed Web of Science ®Google Scholar
• Kindts I, Defraene G, Laenen A, et al. Development of a normal tissue complication probability model for late unfavourable aesthetic outcome after breast-conserving therapy. Acta Oncol. 2018;57:916–923.
   PubMed Web of Science ®Google Scholar
• Brenner DJ, Shuryak I, Jozsef G, et al. Risk and risk reduction of major coronary events associated with contemporary breast radiotherapy. JAMA Intern Med. 2014;174:158–160.
   PubMed Web of Science ®Google Scholar
• Rehammar JC, Jensen MB, McGale P, et al. Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977–2005. Radiother Oncol. 2017;123:299–305.
   PubMed Web of Science ®Google Scholar
• Batin E, Depauw N, Jimenez RB, et al. Reducing X-ray imaging for proton postmastectomy chest wall patients. Pract Radiat Oncol. 2018;8:e266–e274.
   PubMed Web of Science ®Google Scholar
• Batin E, Depauw N, MacDonald S, et al. Can surface imaging improve the patient setup for proton postmastectomy chest wall irradiation? Pract Radiat Oncol. 2016;6:e235–e241.
   PubMed Web of Science ®Google Scholar